Zhou Feng

3PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Food properties (incl. characteristics and health benefits)Behavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 18, 2023
FDA Approval Summary: Ribociclib Indicated for Male Patients with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer.

Jennifer J Gao, Christy L Osgood, Zhou Feng

|Feb 13, 2023
US Food and Drug Administration Approval Summary: Fam-Trastuzumab Deruxtecan-nxki for Human Epidermal Growth Factor Receptor 2-Low Unresectable or Metastatic Breast Cancer.

Preeti Narayan, Asma Dilawari, Christy Osgood

|Aug 12, 2021
Trend changes of national zolpidem users and exposure cases after FDA drug safety communications.

Esther H Zhou, Zhou Feng, Ellen Pinnow

Pageof 1